CLINICAL_TRIALS
trial_result
· 2012-04-11
Clinical Trial Update: Safety Study of a Liposomal Vaccine to Treat Malignant Melanoma [Phase 1]
Summary
A Phase 1 safety study of a liposomal vaccine to treat melanoma has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Lipotek Pty Ltd | Conditions: Melanoma | Phase 1 | Status: COMPLETED